BTAI LAWSUIT ALERT: Levi & Korsinsky Notifies BioXcel Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlinePRNewsWire • 08/17/23
BTAI ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 5, 2023 in the Class Action Filed on Behalf of BioXcel Therapeutics, Inc. ShareholdersPRNewsWire • 08/15/23
Lost Money in BioXcel Therapeutics, Inc? Gibbs Law Group Investigates Potential Securities Law ViolationsBusiness Wire • 08/14/23
BioXcel Therapeutics stock plummets as it cuts jobs in half to focus on AI-powered innovationProactive Investors • 08/14/23
BioXcel Therapeutics Reports Second Quarter 2023 Financial Results and Announces Strategic ReprioritizationGlobeNewsWire • 08/14/23
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind BioXcel Investors of a Lead Plaintiff Deadline of September 5, 2023PRNewsWire • 08/14/23
ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages BioXcel Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BTAIPRNewsWire • 08/11/23
BTAI SHAREHOLDER ALERT: Jakubowitz Law Reminds BioXcel Shareholders of a Lead Plaintiff Deadline of September 5, 2023PRNewsWire • 08/11/23
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of BioXcel Therapeutics, Inc. - BTAIPRNewsWire • 08/10/23
BioXcel Therapeutics, Inc. Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of BioXcel Therapeutics, Inc. of Deadline in Securities Fraud Class Action LawsuitPRNewsWire • 08/09/23
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in BioXcel Therapeutics, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 08/05/23
ROSEN, LEADING TRIAL ATTORNEYS Encourages BioXcel Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BTAIPRNewsWire • 08/04/23
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in BioXcel Therapeutics, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 08/01/23
BioXcel Therapeutics to Report Second Quarter 2023 Financial Results on August 14, 2023GlobeNewsWire • 07/31/23
Kessler Topaz Meltzer & Check, LLP Notification: Deadline Reminder for BioXcel Therapeutics, Inc. (BTAI) Investors in Securities Class Action LawsuitPRNewsWire • 07/30/23